Join to View Full Profile
330 Brookline AveBoston, MA 02215
Phone+1 617-667-5288
Fax+1 617-975-5665
Dr. Garnick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Internal Medicine, 1972 - 1974
Perelman School of Medicine at the University of PennsylvaniaClass of 1972
National Institutes of Health Clinical CenterFellowship, Medical Oncology
Certifications & Licensure
MA State Medical License 1976 - 2027
FL State Medical License 2012 - 2014
PA State Medical License 1973 - 1974
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy Start of enrollment: 2004 May 01
Publications & Presentations
PubMed
- 1 citationsOptimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.David E Crawford, David Albala, Marc B Garnick, Andrew W Hahn, Paul Maroni
The Canadian Journal of Urology. 2024-04-01 - Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.Marc B Garnick, Jason Hafron, E David Crawford
The Journal of Urology. 2024-03-01 - 5 citationsCardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.E David Crawford, Jason M Hafron, Frans Debruyne, Christopher Wallis, Steven Chang
The Journal of Urology. 2024-01-01
Press Mentions
New Surgery for Benign Prostate Hyperplasia Provides Long-Lasting BenefitsJanuary 23rd, 2025- Let's Not Call It CancerJanuary 9th, 2025
- Prostate Cancer: Short-Course Radiation as Effective as Longer-Term TreatmentsDecember 10th, 2024
- Join now to see all
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
